このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Dr. Lal PathLabs バランスシートの健全性
財務の健全性 基準チェック /56
Dr. Lal PathLabsの総株主資本は₹18.9B 、総負債は₹833.0Mで、負債比率は4.4%となります。総資産と総負債はそれぞれ₹24.6Bと₹5.7Bです。 Dr. Lal PathLabsの EBIT は₹4.7Bで、利息カバレッジ比率15.8です。現金および短期投資は₹9.4Bです。
主要情報
4.4%
負債資本比率
₹833.34m
負債
| インタレスト・カバレッジ・レシオ | -18x |
| 現金 | ₹9.43b |
| エクイティ | ₹18.85b |
| 負債合計 | ₹5.71b |
| 総資産 | ₹24.56b |
財務の健全性に関する最新情報
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
May 25Recent updates
We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve
May 21What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You
May 01Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Apr 13These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next
Feb 04Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price
Dec 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around
Oct 12Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 10Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital
Feb 13Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends
Sep 21These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00
Jul 31Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 23Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?
Jun 11These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
May 25Do Dr. Lal PathLabs's (NSE:LALPATHLAB) Earnings Warrant Your Attention?
Apr 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) A Risky Investment?
Feb 17財務状況分析
短期負債: LALPATHLABの 短期資産 ( ₹11.3B ) が 短期負債 ( ₹4.7B ) を超えています。
長期負債: LALPATHLABの短期資産 ( ₹11.3B ) が 長期負債 ( ₹1.1B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: LALPATHLAB総負債よりも多くの現金を保有しています。
負債の削減: LALPATHLABの負債対資本比率は、過去 5 年間で0%から4.4%に増加しました。
債務返済能力: LALPATHLABの負債は 営業キャッシュフロー によって 十分にカバー されています ( 642.7% )。
インタレストカバレッジ: LALPATHLAB支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。